HU9500171D0 - Tetracyclic compounds process and intermediated for their preparation and their use as antitumour agents - Google Patents
Tetracyclic compounds process and intermediated for their preparation and their use as antitumour agentsInfo
- Publication number
- HU9500171D0 HU9500171D0 HU9500171A HU9500171A HU9500171D0 HU 9500171 D0 HU9500171 D0 HU 9500171D0 HU 9500171 A HU9500171 A HU 9500171A HU 9500171 A HU9500171 A HU 9500171A HU 9500171 D0 HU9500171 D0 HU 9500171D0
- Authority
- HU
- Hungary
- Prior art keywords
- intermediated
- preparation
- tetracyclic compounds
- antitumour agents
- compounds process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929215361A GB9215361D0 (en) | 1992-07-20 | 1992-07-20 | Heterocyclic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9500171D0 true HU9500171D0 (en) | 1995-03-28 |
HUT76787A HUT76787A (en) | 1997-11-28 |
Family
ID=10718981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9500171A HUT76787A (en) | 1992-07-20 | 1993-07-19 | Pyrrole ring containing tetracyclic compounds, process for their preparation and pharmaceutical compositions containing them |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0651750A1 (en) |
JP (1) | JPH08502037A (en) |
KR (1) | KR950702563A (en) |
CN (1) | CN1088209A (en) |
AU (1) | AU4579593A (en) |
BG (1) | BG99359A (en) |
CA (1) | CA2140662A1 (en) |
CZ (1) | CZ14995A3 (en) |
FI (1) | FI950229A (en) |
GB (1) | GB9215361D0 (en) |
HR (1) | HRP931066A2 (en) |
HU (1) | HUT76787A (en) |
IL (1) | IL106385A0 (en) |
MX (1) | MX9304355A (en) |
NO (1) | NO950202L (en) |
NZ (1) | NZ254207A (en) |
PL (1) | PL307169A1 (en) |
RU (1) | RU95104939A (en) |
SI (1) | SI9300390A (en) |
SK (1) | SK7595A3 (en) |
WO (1) | WO1994002483A1 (en) |
YU (1) | YU50293A (en) |
ZA (1) | ZA935213B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9401921D0 (en) * | 1994-02-01 | 1994-03-30 | Wellcome Found | Heterocyclic compounds |
GB9413758D0 (en) * | 1994-07-07 | 1994-08-24 | Wellcome Found | Heterocyclic compounds |
GB9804343D0 (en) * | 1998-02-27 | 1998-04-22 | Univ Cardiff | Chemical compounds |
CA2437579C (en) * | 2001-02-14 | 2012-05-01 | Hector F. Deluca | Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
US7419992B2 (en) | 2001-02-14 | 2008-09-02 | Wisconsin Alumni Research Foundation | Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders |
GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
WO2008051523A2 (en) * | 2006-10-23 | 2008-05-02 | Georgetown University | Carbazole derivatives useful as medicaments in cancer therapy |
WO2010019271A1 (en) | 2008-08-15 | 2010-02-18 | Georgetown University | Fluorescent regulators of rassf1a expression and human cancer cell proliferation |
JP2012051804A (en) * | 2008-12-26 | 2012-03-15 | Kyoto Univ | Eg5 INHIBITOR |
KR20160066490A (en) * | 2014-12-02 | 2016-06-10 | 주식회사 씨앤드씨신약연구소 | Heterocyclic derivatives and use thereof |
US11053255B2 (en) | 2015-06-22 | 2021-07-06 | Georgetown University | Synthesis of mahanine and related compounds |
CN109776550B (en) * | 2019-01-17 | 2021-08-10 | 广东轻工职业技术学院 | Alkaloid compound derived from marine fungi and application thereof in preparation of food preservative |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0300688A1 (en) * | 1987-07-21 | 1989-01-25 | FISONS plc | Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them |
US5166204A (en) * | 1989-11-01 | 1992-11-24 | Toyama Chemical Co., Ltd. | Isoindole derivatives and salts thereof and antitumor agent comprising the same |
JPH06503549A (en) * | 1990-03-20 | 1994-04-21 | ザ ウェルカム ファウンデーション リミテッド | Biocidal heteropolycyclic compounds and their use in medicine |
-
1992
- 1992-07-20 GB GB929215361A patent/GB9215361D0/en active Pending
-
1993
- 1993-07-19 KR KR1019950700226A patent/KR950702563A/en not_active Application Discontinuation
- 1993-07-19 AU AU45795/93A patent/AU4579593A/en not_active Abandoned
- 1993-07-19 CN CN93116598A patent/CN1088209A/en active Pending
- 1993-07-19 IL IL106385A patent/IL106385A0/en unknown
- 1993-07-19 SI SI9300390A patent/SI9300390A/en unknown
- 1993-07-19 CZ CZ95149A patent/CZ14995A3/en unknown
- 1993-07-19 ZA ZA935213A patent/ZA935213B/en unknown
- 1993-07-19 SK SK75-95A patent/SK7595A3/en unknown
- 1993-07-19 NZ NZ254207A patent/NZ254207A/en unknown
- 1993-07-19 HR HR931066A patent/HRP931066A2/en not_active Application Discontinuation
- 1993-07-19 JP JP6504272A patent/JPH08502037A/en active Pending
- 1993-07-19 WO PCT/GB1993/001512 patent/WO1994002483A1/en not_active Application Discontinuation
- 1993-07-19 HU HU9500171A patent/HUT76787A/en unknown
- 1993-07-19 CA CA002140662A patent/CA2140662A1/en not_active Abandoned
- 1993-07-19 EP EP93916105A patent/EP0651750A1/en not_active Withdrawn
- 1993-07-19 PL PL93307169A patent/PL307169A1/en unknown
- 1993-07-19 MX MX9304355A patent/MX9304355A/en not_active IP Right Cessation
- 1993-07-19 RU RU95104939/04A patent/RU95104939A/en unknown
- 1993-07-20 YU YU50293A patent/YU50293A/en unknown
-
1995
- 1995-01-18 BG BG99359A patent/BG99359A/en unknown
- 1995-01-19 FI FI950229A patent/FI950229A/en unknown
- 1995-01-19 NO NO950202A patent/NO950202L/en unknown
Also Published As
Publication number | Publication date |
---|---|
CZ14995A3 (en) | 1995-10-18 |
FI950229A (en) | 1995-03-10 |
GB9215361D0 (en) | 1992-09-02 |
HUT76787A (en) | 1997-11-28 |
FI950229A0 (en) | 1995-01-19 |
CA2140662A1 (en) | 1994-02-03 |
EP0651750A1 (en) | 1995-05-10 |
NZ254207A (en) | 1997-03-24 |
SI9300390A (en) | 1994-03-31 |
JPH08502037A (en) | 1996-03-05 |
KR950702563A (en) | 1995-07-29 |
IL106385A0 (en) | 1993-11-15 |
NO950202D0 (en) | 1995-01-19 |
MX9304355A (en) | 1994-04-29 |
PL307169A1 (en) | 1995-05-15 |
YU50293A (en) | 1997-01-08 |
SK7595A3 (en) | 1995-07-11 |
HRP931066A2 (en) | 1995-12-31 |
CN1088209A (en) | 1994-06-22 |
RU95104939A (en) | 1996-10-27 |
NO950202L (en) | 1995-01-19 |
ZA935213B (en) | 1995-01-19 |
AU4579593A (en) | 1994-02-14 |
BG99359A (en) | 1995-11-30 |
WO1994002483A1 (en) | 1994-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL97313A0 (en) | 3-arylcarbonyl-1h-indoles useful as therapeutic agents | |
EP0582201A3 (en) | Process for the preparation of glycerincarbonate | |
HU9303601D0 (en) | Imidazopyridine | |
EP0446340A4 (en) | Use of liposomes as carriers for metalloporphyrins | |
HK1003245A1 (en) | Process for the preparation of potassium clavulanate | |
ZA944807B (en) | Novel indoline derivatives processes for their preparation and their use as cns agents | |
HU9500171D0 (en) | Tetracyclic compounds process and intermediated for their preparation and their use as antitumour agents | |
ZA936197B (en) | Tri-and tetracyclic compounds | |
EP0560109A3 (en) | Process for the preparation of 1-fluorocyclopropyl-methyl-ketone | |
ZA933899B (en) | Thienothiazine derivatives process for their preparation and their use | |
EP0573874A3 (en) | Process for the preparation of beta-naphthylbenzylether | |
IL102025A0 (en) | Tetracyclic antibiotics and processes for their preparation | |
IL99513A0 (en) | Process for the preparation of carbapenem compounds | |
AU2805295A (en) | Tetracyclic derivatives and their use as antitumour agents | |
GB9320940D0 (en) | Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative agents | |
IL106158A0 (en) | Polycyclic compounds | |
EP0582146A3 (en) | Process for the preparation of imidazopyridines | |
ZA939155B (en) | Substituted N-hydroxycinnamamides processes for their preparation compositions containing them and their use | |
ZA934107B (en) | Derivatives of substituted imidazo benzoxazin-1-one and process for their preparation | |
GB9008237D0 (en) | Bicyclic aminohydroxamates as neuroprotective agents | |
HK1013293A1 (en) | Process for the preparation of methylchlorosilane | |
IL104756A0 (en) | Composition for the treatment of glaucoma | |
EP0550871A3 (en) | Process for the preparation of cycloalcanols | |
GB9320769D0 (en) | Tricyclic compounds | |
GB2273500B (en) | Mitosene antitumour agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary protection cancelled due to non-payment of fee |